BSE filing, BSE: 544687. Summary written from the filing by ALFA Finder's alert engine.
Hannah Joseph Hospital Ltd: key numbers
- Share price
- ₹113.00
- Market cap
- ₹256.5 Cr
- Revenue (annual)
- ₹92.05 Cr
- Net profit (annual)
- ₹11.18 Cr
- P/E (TTM)
- 22.9×Sector 52.0×
- Promoter holding
- 71.50%
- FII holding
- 0.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hannah Joseph Hospital Ltd
All →Hannah Joseph Hospital Business Update
Hannah Joseph Hospital received the 'Honours for Healthcare Excellence in Neurosciences' at CII TN MedClave 2026. The award recognises its multidisciplinary Neurosciences services in Tamil Nadu.
Hannah Joseph Hospital Other Announcement
The company filed its quarterly shareholding pattern as mandated by SEBI regulations. This routine disclosure presents the distribution of equity among promoters and public shareholders.
Hannah Joseph Hospital Promoter Buying
Promoter Daniel Dayanand Fenn acquired 2,000 equity shares of Hannah Joseph Hospital Limited through an open market purchase. This transaction increases the total promoter group stake to 71.502%.
- Promoter stake change
- +0.01%
Hannah Joseph Hospital Promoter Buying
Promoter Daniel Dayanand Fenn bought 2,000 open-market Hannah Joseph Hospital shares, raising his stake to 0.053%. A small SAST 29(2) disclosure with no stated transaction price.
- Promoter stake change
- +0.01%
Hannah Joseph Hospital Business Update
Hannah Joseph Hospital Limited received the "Winner" award for "Best Healthcare Digital Initiative" at the 5th CII WR Health Innovation Awards 2026.
- From
- Confederation of Indian Industry (CII)
Hannah Joseph Hospital Business Update
Hannah Joseph Hospital Limited received the AHPI-TN Excellence Award 2026 for Best Single Hospital (above 100 beds) in the Central Zone. This industry recognition highlights its service quality.
Other board meeting date announcements
All →Virat Industries Board Meeting Date
Brahm Virat Industries has scheduled a board meeting for November 5, 2026, to approve Q2 and H1 FY2027 results. Trading window closure began October 1, 2026.
Betex India Board Meeting Date
Betex India scheduled a board meeting for 4 Nov 2026 to approve un-audited Q1 and H1 FY27 results. No financial figures are disclosed in this advance intimation.
Trade Wings Board Meeting Date
Trade Wings Ltd has scheduled a board meeting on 13 November 2026 to consider Q2 FY27 unaudited financial results. No decisions have been made yet.
Multibase India Board Meeting Date
Multibase India intimated that its Board meeting is scheduled for 04 Nov 2026 to consider un-audited financial results for Q1/H1 FY27. No monetary figures or material decisions are announced.
AUDROC Board Meeting Date
Audroc Ltd intimated a Board meeting on November 3, 2026, to approve Q2 and H1 unaudited financial results. The trading window for designated persons is closed.
Max heights Infrastucture Board Meeting Date
Max Heights Infrastructure has intimated a board meeting on 5 November 2026 to approve unaudited financial results for Q1 and H1 FY27. No results or figures are disclosed in this advance notice.